Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia

被引:49
作者
Ahlskog, JE
Waring, SC
Petersen, RC
Esteban-Santillan, C
Craig, UK
O'Brien, PC
Plevak, MF
Kurland, LT
机构
[1] Mayo Clin & Mayo Fdn, Dept Neurol, Div Movement Disorders, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res Clin Epidemiol & Biostat, Rochester, MN 55905 USA
[3] Univ Guam, Sch Nursing & Allied Hlth, Mangilao, GU USA
关键词
D O I
10.1212/WNL.51.6.1672
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: To assess whether olfactory deficits are present in the general Guamanian Chamorro population and to evaluate olfaction in each of the four neurodegenerative disease syndromes of Guam: ALS, pure parkinsonism, pure dementia, and the combined parkinsonism-dementia complex (PDC). Background: Olfactory dysfunction was previously reported in patients with PDC of Guam. Methods: We developed a culturally adjusted olfactory test, battery, derived from the original University of Pennsylvania Smell Identification Test (UPSIT), and administered this to Chamorro residents with ALS (n = 9), pure parkinsonism (n = 9), pure dementia (n = 11), PDC (n = 31), and 53 neurologically normal Chamorro and 25 North American control subjects. Results: Similar, marked olfactory dysfunction was found in all four syndromes of Guamanian neurodegenerative disease. This correlated poorly with measures of parkinsonism and cognition. In the neurologically normal Chamorro control group, six subjects (11%) had very low olfactory scores; these were less than the lowest North American score, raising a question of subclinical neurodegenerative disease. Conclusions: Marked olfactory deficits are common to all four Guamanian neurodegenerative syndromes, and suggest the possibility of similar central neuropathologic substrates. The deficit in the Guamanian ALS group contrasts with idiopathic ALS, in which olfactory function has been reported to be only slightly compromised.
引用
收藏
页码:1672 / 1677
页数:6
相关论文
共 35 条
[1]   Guamanian neurodegenerative disease: Are diabetes mellitus and altered humoral immunity clues to pathogenesis? [J].
Ahlskog, JE ;
Petersen, RC ;
Waring, SC ;
EstebanSantillan, C ;
Craig, UK ;
Maraganore, DM ;
Lennon, VA ;
Kurland, LT .
NEUROLOGY, 1997, 48 (05) :1356-1362
[2]   GUAMANIAN NEURODEGENERATIVE DISEASE - INVESTIGATION OF THE CALCIUM-METABOLISM HEAVY-METAL HYPOTHESIS [J].
AHLSKOG, JE ;
WARING, SC ;
KURLAND, LT ;
PETERSEN, RC ;
MOYER, TP ;
HARMSEN, WS ;
MARAGANORE, DM ;
OBRIEN, PC ;
ESTEBANSANTILLAN, C ;
BUSH, V .
NEUROLOGY, 1995, 45 (07) :1340-1344
[3]   NEUROFIBRILLARY DEGENERATION ON GUAM - FREQUENCY IN CHAMORROS AND NON-CHAMORROS WITH NO KNOWN NEUROLOGICAL DISEASE [J].
ANDERSON, FH ;
RICHARDSON, EP ;
OKAZAKI, H ;
BRODY, JA .
BRAIN, 1979, 102 (MAR) :65-77
[4]   OLFACTORY FUNCTION IN PATIENTS WITH PARKINSONS-DISEASE [J].
ANSARI, KA ;
JOHNSON, A .
JOURNAL OF CHRONIC DISEASES, 1975, 28 (09) :493-497
[5]   OLFACTORY FUNCTION IN ESSENTIAL TREMOR [J].
BUSENBARK, KL ;
HUBER, SJ ;
GREER, G ;
PAHWA, R ;
KOLLER, WC .
NEUROLOGY, 1992, 42 (08) :1631-1632
[6]   NEUROFIBRILLARY CHANGE ON GUAM [J].
CHEN, L .
ARCHIVES OF NEUROLOGY, 1981, 38 (01) :16-18
[7]   PRESENCE OF BOTH ODOR IDENTIFICATION AND DETECTION DEFICITS IN ALZHEIMERS-DISEASE [J].
DOTY, RL ;
REYES, PF ;
GREGOR, T .
BRAIN RESEARCH BULLETIN, 1987, 18 (05) :597-600
[8]   LACK OF MAJOR OLFACTORY DYSFUNCTION IN MPTP-INDUCED PARKINSONISM [J].
DOTY, RL ;
SINGH, A ;
TETRUD, J ;
LANGSTON, JW .
ANNALS OF NEUROLOGY, 1992, 32 (01) :97-100
[9]   OLFACTORY TESTING DIFFERENTIATES BETWEEN PROGRESSIVE SUPRANUCLEAR PALSY AND IDIOPATHIC PARKINSONS-DISEASE [J].
DOTY, RL ;
GOLBE, LI ;
MCKEOWN, DA ;
STERN, MB ;
LEHRACH, CM ;
CRAWFORD, D .
NEUROLOGY, 1993, 43 (05) :962-965
[10]   OLFACTORY DYSFUNCTION IN PARKINSONISM - A GENERAL DEFICIT UNRELATED TO NEUROLOGIC SIGNS, DISEASE STAGE, OR DISEASE DURATION [J].
DOTY, RL ;
DEEMS, DA ;
STELLAR, S .
NEUROLOGY, 1988, 38 (08) :1237-1244